BusinessAXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye IndicationsBy Nasdaq OMXMar 21, 2017, 1:01 PM UTC
BusinessAXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye IndicationsBy Nasdaq OMXMar 21, 2017, 1:01 PM UTC
BusinessETST Announces Recruitment of Key Individuals for its Two Subsidiaries and the Leasing of a Manufacturing Facility to Produce its MSN-2 Medical Device.By Nasdaq OMXMar 14, 2017, 12:01 PM UTC
BusinessETST Announces Recruitment of Key Individuals for its Two Subsidiaries and the Leasing of a Manufacturing Facility to Produce its MSN-2 Medical Device.By Nasdaq OMXMar 14, 2017, 12:01 PM UTC
BusinessIBRI, Lilly, Dow AgroSciences Partner to Develop Shared Database to Assess Molecular SafetyBy Nasdaq OMXMar 8, 2017, 3:30 PM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
BusinessEarth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent StudiesBy Nasdaq OMXFeb 23, 2017, 11:45 AM UTC
BusinessCureGrail Launches Collaborative, System-Level Platform to Accelerate Drug Development & Cure DiscoveryBy Nasdaq OMXFeb 21, 2017, 5:46 PM UTC
